Store
Autoimmune Immunoassay Market Opportunities, 2021-2026
Publication Date: September 23, 2021
Tags: Cell and Gene Therapy, COVID-19, Diagnostic Instruments, Immunoassay, In Vitro Diagnostics (IVD), Patient Monitoring and Telehealth
Pages: 65
SKU: 21-033
Kalorama Information’s latest report, Autoimmune Immunoassay Market Opportunities, 2021-2026, delves into the expansive and evolving landscape of diagnostic tests for autoimmune diseases. As the market for autoimmune diagnostics continues to grow, substantial opportunities for innovation and advancement emerge. This report provides a comprehensive analysis of current and future market prospects, highlighting the potential for revenue growth and competitive dynamics.
Key Highlights of the Report:
- Market Potential: The report emphasizes the significant growth potential in the autoimmune IVD diagnostic testing market. It outlines the competitive landscape, identifying opportunities for new entrants to capitalize on innovative testing solutions.
- Test Options and Overlap: An overview of the various autoimmune tests available and in development, discussing the overlap and unique aspects of these tests. The continued discovery of autoimmune conditions presents further opportunities for accurate diagnostic test development.
Scope and Methodology:
- Geographic Scope: The report offers a global perspective, with detailed information on specific geographical regions, world autoimmune demographics, and general market issues.
- Market Summary: Includes total market values, market analysis by region, and test segment, providing a thorough understanding of the current market scenario.
- Key Company Profiles: Profiles of major companies involved in the autoimmune immunoassay market, offering insights into their strategies and market positioning.
- Market Data: All data pertains to the global market at the manufacturers’ level, excluding services. The base year for data is 2021, with compound annual growth rates (CAGRs) provided for the 2021-2026 period.
- Forecasted Market Analysis: The forecast is based on demographic trends, new developments, innovative technology, and global expansion.
Table: Autoimmune Immunoassay Market Analysis, 2021-2026 ($ millions)
| Year | Revenues ($millions) |
| 2021 | $XX Million |
| 2026 | $XX Million |
| Compound Annual Growth Rate (%) | |
| 2021-2026 | XX% |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
CHAPTER 1. EXECUTIVE SUMMARY
- INTRODUCTION
- SCOPE AND METHODOLOGY
- SIZE AND GROWTH OF THE MARKET
-
- Table 1-1: Autoimmune Immunoassay Market Analysis 2021-2026($ millions)
-
- KEY ISSUES AND TRENDS AFFECTING THE MARKET
- COMPETITIVE OUTLOOK
- CONCLUSION HIGHLIGHTS
- Conclusion 1: There are vast opportunities for manufacturers of autoimmune diagnostic testing products in the autoimmune arena
- Conclusion 2: Women are disproportionately affected by autoimmune disease
- Conclusion 3: Testing needs to be cost effective but precise to identify autoimmune diseases
- Conclusion 4: Sophistication in testing is leading to more automated effective testing
- Conclusion 5: Proteonomic research is furthering the discovery of autoimmune disease markers
CHAPTER 2: INTRODUCTION AND OVERVIEW
- AUTOIMMUNITY
- TYPES OF AUTOIMMUNE DISEASES
- Rheumatoid Arthritis
- Autoimmune Gastrointestinal Disease
-
- Celiac Disease
-
- Inflammatory bowel disease
- SYSTEMIC LUPUS ERYTHEMATOSUS
- AUTOIMMUNE THYROID DISEASE
- MULTIPLE SCLEROSIS
- SJOGREN’S SYNDROME
- MYASTHENIA GRAVIS
- TYPE 1 DIABETES
- AUTOIMMUNE TESTING
- Types of Tests
- Anti-nuclear Antibody
- Enzyme-linked Immunosorbent Assay
- Rheumatoid Factor
- ESR/CRP
- IFA/ Anti-neutrophil Cytoplasmic Antibodies (ANCA)
- PREVALENCE AND DEMOGRAPHICS OF AUTOIMMUNE DISEASE
-
- Table 2-1: Prevalence of Selected Autoimmune Diseases 2020
-
- (per 100,000 population est)
-
- Prevalence in Women
-
- Table 2-2: Male to Female Ratio of Autoimmune Disease 2020
-
CHAPTER 3: EMERGING TRENDS
- COVID-19
- PATIENT ENGAGEMENT/PATIENT-CENTERED HEALTHCARE
- TELEHEALTH
- INNOVATING POC
-
- Table 3-1: Selected POC Test Innovations
-
- Table 3-2: Selected POC Immunoassay Test Platforms
-
- AUTOMATED AUTOIMMUNE DIAGNOSTIC PLATFORMS
- CELL AND GENE THERAPY OPPORTUNITIES
CHAPTER 4: MARKET PARTICIPANTS
- AESKU. DIAGNOSTICS GMBH & CO KG
-
- Table 4-1: AESKU Corporate Summary
- Company Overview
-
- BINDING SITE GROUP LTD. (THE)
-
- Table 4-2: Binding Site Corporate Summary
- Company Overview
-
- BIOMERICA, INC.
-
- Table 4-3: Biomerica Corporate Summary
- Company Overview
-
- Table 4-4: Biomerica Corporation Revenue (2017-2020) ($ millions)
-
- BIO-RAD LABORATORIES INC.
-
- Table 4-5: Bio-Rad Labs Corporate Summary
- Company Overview
-
- Table 4-6: Bio-Rad Corporation Revenue (2017-2020) ($ millions)
-
- DIASORIN, INC.
-
- Table 4-7: DiaSorin Corporate Summary
- Company Overview
-
- Table 4-6: DiaSorin Corporation Revenue (2017-2020) ($ millions)
-
- EUROIMMUN AG
-
- Table 4-7: EUROIMMUN Corporate Summary
- Company Overview
-
- HOB BIOTECH GROUP
-
- Table 4-8: HOB Biotech Corporate Summary
- Company Overview
-
- INOVA DIAGNOSTICS, INC.
-
- Table 4-9: INOVA Diagnostics Corporate Summary
- Company Overview
-
- ORGENTEC DIAGNOSTIKA
-
- Table 4-10: ORGENTEC Corporate Summary
- Company Overview
-
- ROCHE DIAGNOSTIC CORPORATION
-
- Table 4-11: Roche Diagnostic Corporate Summary
- Company Overview
-
- Table 4-12: Roche Diagnostics (2017-2020) ($ millions)
-
- SIEMENS HEALTHINEERS GMBH
-
- Table 4-13: Siemens Healthineers Corporate Summary
- Company Overview
-
- Table 4-14: Siemens Healthineers (2017-2020) ($ millions)
-
- THERADIG
-
- Table 4-15: Theradig Corporate Summary
- Company Overview
-
- THERMO FISHER SCIENTIFIC
-
- Table 4-16: Thermo Fisher Corporate Summary
- Company Overview
-
- Table 4-17: Thermo Fisher Corporation Revenue (2017-2020) ($ millions)
-
- TOSOH BIOSCIENCE
-
- Table 4-18: Tosoh Bioscience Corporate Summary
- Company Overview
-
- TRINITY BIOTECH PLC.
-
- Table 4-19: Trinity Biotech Corporate Summary
- Company Overview
-
- Table 4-20: Trinity Biotech Revenue (2017-2020) ($ millions)
-
- WERFEN
-
- Table 4-21: Werfen Corporate Summary
- Company Overview
-
- Table 4-22: Werfen Corporation Revenue (2017-2020) ($ millions)
-
- ZEUS SCIENTIFIC
-
- Table 4-23: ZEUS Scientific Corporate Summary
- Company Overview
-
CHAPTER 5: MARKET ANALYSIS
- MARKET OVERVIEW
-
- Table 5-1: Autoimmune Immunoassay Market Analysis 2021-2026($ millions)
-
- MARKET BY REGION
- Autoimmune Immunoassay Testing Market by Region
-
- Table 5-2: Autoimmune Immunoassay Market by Region 2021
-
- Table 5-3: Autoimmune Immunoassay Market by European Country, 2021
-
- Table 5-4: Autoimmune Immunoassay Market by Rest of World Countries, 2021
- MARKET BY SEGMENT
-
- Table 5-5: Autoimmune Immunoassay Market Revenues by Segment Type, 2021 (in $millions)
-
- Table 5-6: Autoimmune Immunoassay Market Segment Type by Percent, 2021
-
- AUTOIMMUNE IMMUNOASSAY MARKET BY DISEASE TYPE
-
- Figure 5-1: Autoimmune Immunoassay Market by Disease Type % 2021
-
- COMPETITIVE ANALYSIS
- INOVA
- Thermo Fisher


